Form 4: Doximity Director Sells Shares Under 10b5-1 Plan

A Doximity director sold 6,360 shares of Class A Common Stock for $66.2981 per share under a pre-arranged trading plan.

Summary

• Timothy S. Cabral, a Director of Doximity, Inc. (DOCS), disposed of 6,360 shares of Class A Common Stock.
• The transaction occurred on September 2, 2025, at a weighted-average price of $66.2981 per share.
• The sale was executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Cabral on February 13, 2025.
• Following this transaction, Mr. Cabral beneficially owns 3,221 shares of Class A Common Stock directly.
• The shares were sold in multiple transactions ranging from $65.8300 to $66.6400 per share.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned liquidity event rather than a reactive decision based on new material information.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive sale.

Negatives

• A director reduced their direct beneficial ownership in the company by 6,360 shares.

Future Outlook

NA

Industry Context

This is a routine insider transaction and does not provide specific insights into broader industry trends or Doximity's competitive position.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but generally viewed as a planned event due to the 10b5-1 plan, mitigating concerns about management's confidence.

Key Dates

Recommendation

A single insider sale under a Rule 10b5-1 plan by a director is generally considered a routine liquidity event and does not typically warrant a change in investment recommendation. It does not signal a fundamental shift in the company's prospects or management's confidence beyond what was already known when the plan was adopted.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Timothy S. Cabral, Director